Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform

NCT01120639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Cancer of Brain and Nervous System
Glioblastoma Multiforme

Interventions

DRUG: Temozolomide
PROCEDURE: Stereotactic Radiosurgery (SRS)

Sponsor

Stanford University